Articles from Nexlife

Standard compounded semaglutide injections prescribed through NexLife are $119 a month on the 12-month plan or $139 month to month at every weekly dose from 0.25 mg to 2.4 mg; standard compounded tirzepatide injections are $139 a month on the 12-month plan or $169 month to month at every weekly dose from 2.5 mg to 15 mg. Compounded medications are not FDA-approved.

WILMINGTON, Del., Oct. 12, 2026 (GLOBE NEWSWIRE) -- NexLife announces a new report, the October 2026 NexLife GLP-1 Price Index, on the monthly prices of compounded tirzepatide and compounded semaglutide at online telehealth programs in the United States. This can be accessed in full here: https://nexlife.us/pages/glp-1-price-index

Physician-led telehealth platform keeps compounded semaglutide and tirzepatide at one price from first dose through maintenance, with independent batch testing, one-to-two-day expedited delivery and $377 in nutrition, coaching and provider support included at no added cost.